Sumant Ramachandra
Vermogen: 173 300 $ op 31-05-2026
Vermogen: 173 300 $ op 31-05-2026
Momenteel is Sumant Ramachandra Senior VP, Chief Science & Technology Officer bij Baxter International, Inc. Dr. Ramachandra zit ook in de raad van bestuur van Arog Pharmaceuticals, Inc. Dr. Ramachandra was voorheen Chief Scientific Officer & SVP-Regulatory Affairs bij Hospira, Inc., President-Research & Development bij Synta Pharmaceuticals Corp., Senior Vice President, Head-Research & Development bij Pfizer Essential Health en Vice President bij Schering-Plough Corp. Hij behaalde een doctoraat aan de Rutgers State University of New Jersey, een doctoraat aan de University of Medicine & Dentistry of New Jersey en een MBA aan The Wharton School van de Universiteit van Pennsylvania.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-06-2026 | 10.000 ( 0,04% ) | 173 300 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Directeur/Bestuurslid | 01-11-2024 |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Directeur/Bestuurslid | - |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Algemeen Directeur | 20-04-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Algemeen Directeur | 31-10-2024 |
| BAXTER INTERNATIONAL INC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2021 |
| HOSPIRA, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 05-05-2013 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01-01-2008 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 12 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatments | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Health Technology |
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau